A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

“While others back into the future, we lead the way forward—with curiosity, with science, with knowledge, but also compassion as our guiding star,” said Aida Hadžialić, Finance Regional Councilor and Chair of the Regional Executive Board in Region Stockholm, at the inauguration.

More than 600 participants from industry, academia, municipalities, and society gathered in Flemingsberg to celebrate the shared goal: accelerating the development and accessibility of tomorrow’s treatments.

“Advanced therapies represent a paradigm shift. They offer possibilities that were previously unimaginable,” stated Annika Östman Wernerson, President of Karolinska Institutet.

Throughout the day, ongoing research and breakthroughs were presented in cell and gene therapy, treatment of neonatal lung disease, Parkinson’s disease, and immunotherapies. The program highlighted the pioneering progress already being made within ATMP in Flemingsberg, where the center symbolizes a major investment in accelerating the work of future medicine even further. Knut Steffensen, Director of the Karolinska ATMP Center, summarized the vision:

“We will cure and alleviate tomorrow, what no one can cure and alleviate today.”

With the Karolinska ATMP Center now officially inaugurated, the work on future medicine takes a major step forward – where collaboration, knowledge, and compassion go hand in hand to give patients hope for a brighter future. At Flemingsberg Science Foundation, we are proud to have supported this important day for future medicine and treatments, and to celebrate all those working to drive progress forward.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

BIO-Europe – A Conference for Future Medical Innovations

BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.

The Sustainable Societies of the Future: Social Capital, Green Transition, and the Power of Communities

We share our insights from two intensive days in Luleå focused on green industrial transformation, the significance and growth potential of the gaming industry, and how to build relationship-driven communities. We return to Flemingsberg with a continued strong belief in the immense potential of collaboration and cooperation.

Previous 181920 Next